Incessant threat of COVID-19 variants: Highlighting need for a mix of FDA-approved artificial intelligence tools and community pharmacy services
- PMID: 34391673
- PMCID: PMC8294695
- DOI: 10.1016/j.sapharm.2021.07.018
Incessant threat of COVID-19 variants: Highlighting need for a mix of FDA-approved artificial intelligence tools and community pharmacy services
Abstract
Seamless integration of artificial intelligence (AI) technology, especially FDA-approved AI tools, in community pharmacies can build increasingly effective and easy care pathways, thereby minimizing burden on healthcare system, and ensuring compliance to preventive measure through limiting hospital visits. In this regard, the WHO needs to enlist and provide guidance on most promising AI tools that can be implemented in community pharmacy settings.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
We declare no competing interests.
References
-
- International Pharmaceutical Federation . International Pharmaceutical Federation; The Hague, Netherlands: 2021. FIP Digital Health in Pharmacy Education.
-
- World Health Organization Ethics and governance of artificial intelligence for health: WHO guidance. World Health Organization. 2021
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
